Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 HAL Allergy Extends Manufacturing Activities | Contract Pharma

What are you searching for?

Sign in
Breaking News

HAL Allergy Extends Manufacturing Activities

Dutch inspectorate grants permit extension

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

HAL Allergy B.V. is extending its GMP contract manufacturing activities for clinical batch supply of both recombinant and viral products. The Dutch inspectorate granted the permit extension following an inspection of operational activities in June.
 
Harry Flore, chief executive officer of HAL Allergy, said, “The fact that the Dutch authorities extended our GMP permit is a big step forward in our goal of becoming a key biotech service company. Our team of specialists offers clients reliable and effective services. Modern production and laboratory facilities and over 50 years experience in vaccine production will be key asset in partnerships with our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics